GIA
ACOR

Gargoyle Investment Advisor’s Acorda Therapeutics ACOR Stock Holding History

Gargoyle Investment Advisor’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-93
Closed -$264K – 160
2018
Q1 		$264K Buy
+93
New +$278K 0.11% 143
2017
Q4 		– Sell
-110
Closed -$311K – 200
2017
Q3 		$311K Hold
110
– – 0.11% 140
2017
Q2 		$259K Hold
110
– – 0.1% 160
2017
Q1 		$276K Buy
+110
New +$317K 0.11% 166
2015
Q4 		– Sell
-122
Closed -$389K – 183
2015
Q3 		$389K Hold
122
– – 0.16% 149
2015
Q2 		$489K Hold
122
– – 0.19% 149
2015
Q1 		$489K Buy
122
+10
+9% +$45.8K 0.18% 138
2014
Q4 		$547K Buy
+112
New +$481K 0.2% 125
2013
Q4 		– Sell
-128
Closed -$527K – 136
2013
Q3 		$527K Buy
+128
New +$551K 0.33% 82

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gargoyle Investment Advisor's ACOR Position: Q2 2018 in Review

Gargoyle Investment Advisor sold out of Acorda Therapeutics (ACOR) in Q2 2018, closing a stake of 93 shares — an estimated $264K sold.

Gargoyle Investment Advisor first reported a position in ACOR in Q3 2013 and held it in 9 quarters. The position peaked at $547K in Q4 2014. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2018.

  • Gargoyle Investment Advisor reported no remaining Acorda Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 93 Acorda Therapeutics shares in Q2 2018, an estimated $264K.
  • Gargoyle Investment Advisor first reported a position in Acorda Therapeutics in Q3 2013 and held it in 9 quarters.
  • Gargoyle Investment Advisor's Acorda Therapeutics position peaked at $547K in Q4 2014.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2018.

Based on Gargoyle Investment Advisor's 13F filing for Q2 2018, filed 14 Aug 2018.